CD38 inhibitor 1 (compound 78c)

製品コードS8960 バッチS896005

印刷

化学情報

Synonyms

CD38-IN-78c, MDK-7553

Storage
(From the date of receipt)

3 years -20°C powder

化学式

C₂₂H₂₇N₃O₃S

分子量

413.53

CAS No.

1700637-55-3

Solubility (25°C)*

体外

DMSO

14 mg/mL (33.85 mM)

Water

Insoluble

Ethanol

Insoluble

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension

CMC-NA

≥5mg/ml

Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	CD38 inhibitor 1 (compound 78c, CD38-IN-78c, MDK-7553) is a potent inhibitor of CD38 with IC50 of 7.3 nM and 1.9 nM for human CD38 and mouse CD38, respetively.
in vitro	CD38 inhibitor 1 (compound 78c) increases NAD+ levels, resulting in activation of pro-longevity and health span-related factors including sirtuins, AMPK, and PARPs.^[2]
in vivo	CD38 inhibitor 1 (compound 78c) is found to not only be a very potent inhibitor, but also had suitable physiochemical properties to serve as a robust tool for in vivo studies. In addition, this compound is able to elevate NAD in both liver and gastrocnemius tissue when dosed orally in a DIO mouse.^[1]

プロトコル(参考用のみ)

細胞アッセイ	細胞株	HEK293T, MEFs, A549, Jurkat T and AML12 cells
	濃度	0.5 μM, 0.2 - 0.5 μM
	反応時間	16 h, 24 h
	実験の流れ	To test the reversibility of the CD38 inhibitor 1 (compound 78c), A549 cells were treated with vehicle or 0.5 μM 78c for 16 hours. Then, cells were washed and incubated with (this compound) or without (this compound+release) this compound for another 8 hours.
動物実験	動物モデル	DIO C57Bl6 mice
	投薬量	30 mg/kg, 2 mg/kg
	投与方法	Oral gavage, IV

参考

https://pubmed.ncbi.nlm.nih.gov/25828863/
https://pubmed.ncbi.nlm.nih.gov/29719225/

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention [ Leukemia, 2025, 10.1038/s41375-025-02551-4]	PubMed: 40057636
Bionic bearing-inspired lubricating microspheres with Immunomodulatory effects for osteoarthritis therapy [ J Nanobiotechnology, 2025, 23(1):457]	PubMed: 40542398
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism [ Cell Rep Med, 2024, 5(2):101400]	PubMed: 38307031
Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects [ Cell Rep Med, 2023, S2666-3791(23)00310-5]	PubMed: 37586364
Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects [ Cell Rep Med, 2023, 4(9):101157]	PubMed: 37586364
Comprehensive Proteomics Analysis Identifies CD38-Mediated NAD+ Decline Orchestrating Renal Fibrosis in Pediatric Patients With Obstructive Nephropathy [ Mol Cell Proteomics, 2023, 22(3):100510]	PubMed: 36804530
eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation [ J Biol Chem, 2023, 299(9):105177]	PubMed: 37611825
Role of Integrin β1 in the progression and chemo-resistance of esophageal squamous cell carcinoma [ Orthop Surg, 2022, 10.1111/os.13258]	PubMed: 35441488

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。